Literature DB >> 1974905

A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales.

S Kerr1, G E Kerr, C A Mackintosh, R R Marples.   

Abstract

For a six-month period between October 1987 and March 1988, 660 isolates of methicillin-resistant Staphylococcus aureus (MRSA) from 570 patients were sent to the Staphylococcus Reference Laboratory at Colindale to supplement the National reporting survey of MRSA in England and Wales. The isolates were characterized by phage typing, antibiotic susceptibility and by selected biochemical tests. Patient details were also surveyed. Fourteen strains affected more than one hospital and were called multi-hospital epidemic strains. One strain, EMRSA-1, accounted for more than 40% of isolates and of patients. Other epidemic strains were defined. Ten additional strains were restricted to single hospitals. Only 25 primary isolates were non-typable but 67 sporadic typable strains occurred. The patients affected were approximately equally either infected or colonized. The sexes were represented equally. Orthopaedic and geriatric wards were over-represented. Epidemic strains were clumping factor positive while some sporadic strains were weak producers. Urea alkalinization and protein A production could supplement phage typing and antibiotic resistance in strain recognition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974905     DOI: 10.1016/0195-6701(90)90047-r

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  30 in total

1.  Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15).

Authors:  G L O'Neill; S Murchan; A Gil-Setas; H M Aucken
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  How significant are methicillin-resistant Staphylococcus aureus in long term geriatric care?

Authors:  R R Marples
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

4.  Staphylococcus aureus resistant to methicillin.

Authors:  P Aparicio; A Vindel; T Alarcon; J F Richardson; R R Marples; B D Cookson
Journal:  BMJ       Date:  1991-05-04

5.  Emergence, spread, and characterization of phage variants of epidemic methicillin-resistant Staphylococcus aureus 16 in England and Wales.

Authors:  S Murchan; H M Aucken; G L O'neill; M Ganner; B D Cookson
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  An epidemic methicillin-resistant strain of Staphylococcus aureus in Spain.

Authors:  P Aparicio; J Richardson; S Martin; A Vindel; R R Marples; B D Cookson
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

7.  Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus.

Authors:  W J Van Wamel; A C Fluit; T Wadström; H van Dijk; J Verhoef; C M Vandenbroucke-Grauls
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

8.  Methicillin-resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns.

Authors:  A C Hunt; B Edwards; E K Girvan; B Cosgrove; G F S Edwards; I M Gould
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

9.  Pathogenicity potential of Staphylococcus pseudintermedius strains isolated from canine carriers and from dogs with infection signs.

Authors:  Katarzyna Garbacz; Sabina Zarnowska; Lidia Piechowicz; Krystyna Haras
Journal:  Virulence       Date:  2013-01-17       Impact factor: 5.882

10.  Evolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina.

Authors:  Claudia Sola; Paulo Cortes; Hector A Saka; Ana Vindel; José Luis Bocco
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.